Andrew D.C. La Frence Vyant Bio, Inc. (VYNT) insider trading activity

Andrew D.C. La Frence is Chief Financial Officer of Vyant Bio, Inc.. Currently has a direct ownership of 34,336 shares of VYNT, which is worth approximately $0. The most recent transaction as insider was on Nov 23, 2021, when has been sold 5,000 shares (Common Stock, $0.0001 par value) at a price of $2.0 per share, resulting in proceeds of $10,000. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 34.3K

0% 3M change

0% 12M change

Total Value Held $0

Andrew D.C. LaFrence Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Nov 23 2021	BUY Open market or private purchase	$10,000 $2.0 p/Share	5,000 Added 12.71%	34,336 Common Stock, $0.0001 ...
May 20 2021	BUY Open market or private purchase	$9,840 $3.28 p/Share	3,000 Added 8.49%	32,336 Common Stock, $0.0001 ...
Mar 30 2021	BUY Other acquisition or disposition	-	29,336 Added 50.0%	29,336 Common Stock, $0.0001 ...

Also insider at

KRMD

KORU Medical Systems, Inc. Healthcare

Chief Financial Officer

NSYS

NORTECH SYSTEMS INC Technology

CHIEF FINANCIAL OFFICER

ADL